1 | developing | 10,220 |
2 | acquiring | 400 |
3 | industrialized | 308 |
4 | contracting | 254 |
5 | high-income | 194 |
6 | industrialised | 104 |
7 | papua | 93 |
8 | aborting | 15 |
9 | fathead | 15 |
10 | less-developed | 13 |
11 | lami | 8 |
12 | reheated | 7 |
13 | westernised | 7 |
14 | sylvinite | 5 |
15 | abates | 4 |
16 | batan | 4 |
17 | children-third | 4 |
18 | de-conditioned | 4 |
19 | industrializing | 4 |
20 | infantile-type | 4 |
21 | low-/middle-income | 4 |
22 | amalgamating | 3 |
23 | context-based | 3 |
24 | ffa-induced | 3 |
25 | hsp27-mediated | 3 |
26 | shunde | 3 |
27 | 11,669 | 2 |
28 | 3076 | 2 |
29 | 5641 | 2 |
30 | 7183 | 2 |
31 | chemo/radiotherapy-induced | 2 |
32 | chiloe | 2 |
33 | cornwallis | 2 |
34 | dark-eyed | 2 |
35 | eastern-asia | 2 |
36 | full-fledged | 2 |
37 | immunologically-based | 2 |
38 | jato | 2 |
39 | locally-prepared | 2 |
40 | newly-abstinent | 2 |
41 | non-3-hydroxylated | 2 |
42 | nonindustrialized | 2 |
43 | north-african | 2 |
44 | oscine | 2 |
45 | post-vertebroplasty | 2 |
46 | shs-treated | 2 |
47 | tbi-hsct-related | 2 |
48 | third-world | 2 |
49 | wnv-infected | 2 |
50 | yongxing | 2 |
51 | 1,200-1,300 | 1 |
52 | 1,660,290 | 1 |
53 | 114,000-304,000 | 1 |
54 | 115,425 | 1 |
55 | 119,070 | 1 |
56 | 12,403 | 1 |
57 | 125,837 | 1 |
58 | 129ml | 1 |
59 | 14,447 | 1 |
60 | 15,396 | 1 |
61 | 180,400 | 1 |
62 | 21,750 | 1 |
63 | 23,765 | 1 |
64 | 299,809 | 1 |
65 | 2cda | 1 |
66 | 36,492 | 1 |
67 | 39,714 | 1 |
68 | 39.7+/-2.0 | 1 |
69 | 47,813 | 1 |
70 | 49,240 | 1 |
71 | 5213 | 1 |
72 | 5235 | 1 |
73 | 6,536 | 1 |
74 | 6,877 | 1 |
75 | 65,358 | 1 |
76 | 6th-8th | 1 |
77 | 76,147 | 1 |
78 | advanced/ultra-advanced | 1 |
79 | anglo-saxan | 1 |
80 | aspartame-induced | 1 |
81 | assateague | 1 |
82 | ca-mrsa-endemic | 1 |
83 | cage-housed | 1 |
84 | cin-related | 1 |
85 | colares | 1 |
86 | developing/developed | 1 |
87 | developing/low-resource | 1 |
88 | eastern-european | 1 |
89 | economically-developing | 1 |
90 | febuxostat-a | 1 |
91 | greek-speaking | 1 |
92 | gugulipid-a | 1 |
93 | health-defined | 1 |
94 | high-income/middle-income | 1 |
95 | highly-conservative | 1 |
96 | je-endemic | 1 |
97 | kofe | 1 |
98 | less-refined | 1 |
99 | low-to-middle-income | 1 |
100 | lower-economic | 1 |
101 | lower-income/middle-income | 1 |
102 | medicine-demands | 1 |
103 | medium-to-low-income | 1 |
104 | non-oecd | 1 |
105 | non-socialist | 1 |
106 | nonindustrialised | 1 |
107 | often-unrecognised | 1 |
108 | poliomyelitis-endemic | 1 |
109 | press-fitting | 1 |
110 | resources-limited | 1 |
111 | semantics-enabled | 1 |
112 | seronegative/unknown | 1 |
113 | severe/treated | 1 |
114 | skateboard | 1 |
115 | snrpn | 1 |
116 | tas-102-a | 1 |
117 | tbii-positive | 1 |
118 | tbrf-endemic | 1 |
119 | thepollen | 1 |
120 | treatment-demand | 1 |
121 | uk-residing | 1 |
122 | unpriced | 1 |
123 | vaccine-driven | 1 |
124 | voices-3 | 1 |
125 | western/industrialized | 1 |
1 | 1,200-1,300 | 1 |
2 | 1,660,290 | 1 |
3 | 11,669 | 2 |
4 | 114,000-304,000 | 1 |
5 | 115,425 | 1 |
6 | 119,070 | 1 |
7 | 12,403 | 1 |
8 | 125,837 | 1 |
9 | 129ml | 1 |
10 | 14,447 | 1 |
11 | 15,396 | 1 |
12 | 180,400 | 1 |
13 | 21,750 | 1 |
14 | 23,765 | 1 |
15 | 299,809 | 1 |
16 | 2cda | 1 |
17 | 3076 | 2 |
18 | 36,492 | 1 |
19 | 39,714 | 1 |
20 | 39.7+/-2.0 | 1 |
21 | 47,813 | 1 |
22 | 49,240 | 1 |
23 | 5213 | 1 |
24 | 5235 | 1 |
25 | 5641 | 2 |
26 | 6,536 | 1 |
27 | 6,877 | 1 |
28 | 65,358 | 1 |
29 | 6th-8th | 1 |
30 | 7183 | 2 |
31 | 76,147 | 1 |
32 | abates | 4 |
33 | aborting | 15 |
34 | acquiring | 400 |
35 | advanced/ultra-advanced | 1 |
36 | amalgamating | 3 |
37 | anglo-saxan | 1 |
38 | aspartame-induced | 1 |
39 | assateague | 1 |
40 | batan | 4 |
41 | ca-mrsa-endemic | 1 |
42 | cage-housed | 1 |
43 | chemo/radiotherapy-induced | 2 |
44 | children-third | 4 |
45 | chiloe | 2 |
46 | cin-related | 1 |
47 | colares | 1 |
48 | context-based | 3 |
49 | contracting | 254 |
50 | cornwallis | 2 |
51 | dark-eyed | 2 |
52 | de-conditioned | 4 |
53 | developing | 10,220 |
54 | developing/developed | 1 |
55 | developing/low-resource | 1 |
56 | eastern-asia | 2 |
57 | eastern-european | 1 |
58 | economically-developing | 1 |
59 | fathead | 15 |
60 | febuxostat-a | 1 |
61 | ffa-induced | 3 |
62 | full-fledged | 2 |
63 | greek-speaking | 1 |
64 | gugulipid-a | 1 |
65 | health-defined | 1 |
66 | high-income | 194 |
67 | high-income/middle-income | 1 |
68 | highly-conservative | 1 |
69 | hsp27-mediated | 3 |
70 | immunologically-based | 2 |
71 | industrialised | 104 |
72 | industrialized | 308 |
73 | industrializing | 4 |
74 | infantile-type | 4 |
75 | jato | 2 |
76 | je-endemic | 1 |
77 | kofe | 1 |
78 | lami | 8 |
79 | less-developed | 13 |
80 | less-refined | 1 |
81 | locally-prepared | 2 |
82 | low-/middle-income | 4 |
83 | low-to-middle-income | 1 |
84 | lower-economic | 1 |
85 | lower-income/middle-income | 1 |
86 | medicine-demands | 1 |
87 | medium-to-low-income | 1 |
88 | newly-abstinent | 2 |
89 | non-3-hydroxylated | 2 |
90 | non-oecd | 1 |
91 | non-socialist | 1 |
92 | nonindustrialised | 1 |
93 | nonindustrialized | 2 |
94 | north-african | 2 |
95 | often-unrecognised | 1 |
96 | oscine | 2 |
97 | papua | 93 |
98 | poliomyelitis-endemic | 1 |
99 | post-vertebroplasty | 2 |
100 | press-fitting | 1 |
101 | reheated | 7 |
102 | resources-limited | 1 |
103 | semantics-enabled | 1 |
104 | seronegative/unknown | 1 |
105 | severe/treated | 1 |
106 | shs-treated | 2 |
107 | shunde | 3 |
108 | skateboard | 1 |
109 | snrpn | 1 |
110 | sylvinite | 5 |
111 | tas-102-a | 1 |
112 | tbi-hsct-related | 2 |
113 | tbii-positive | 1 |
114 | tbrf-endemic | 1 |
115 | thepollen | 1 |
116 | third-world | 2 |
117 | treatment-demand | 1 |
118 | uk-residing | 1 |
119 | unpriced | 1 |
120 | vaccine-driven | 1 |
121 | voices-3 | 1 |
122 | western/industrialized | 1 |
123 | westernised | 7 |
124 | wnv-infected | 2 |
125 | yongxing | 2 |
1 | 39.7+/-2.0 | 1 |
2 | 114,000-304,000 | 1 |
3 | 1,200-1,300 | 1 |
4 | 180,400 | 1 |
5 | 49,240 | 1 |
6 | 21,750 | 1 |
7 | 119,070 | 1 |
8 | 1,660,290 | 1 |
9 | 5641 | 2 |
10 | 36,492 | 1 |
11 | voices-3 | 1 |
12 | 12,403 | 1 |
13 | 5213 | 1 |
14 | 47,813 | 1 |
15 | 7183 | 2 |
16 | 39,714 | 1 |
17 | 115,425 | 1 |
18 | 5235 | 1 |
19 | 23,765 | 1 |
20 | 6,536 | 1 |
21 | 3076 | 2 |
22 | 15,396 | 1 |
23 | 125,837 | 1 |
24 | 76,147 | 1 |
25 | 14,447 | 1 |
26 | 6,877 | 1 |
27 | 65,358 | 1 |
28 | 299,809 | 1 |
29 | 11,669 | 2 |
30 | tas-102-a | 1 |
31 | gugulipid-a | 1 |
32 | febuxostat-a | 1 |
33 | 2cda | 1 |
34 | eastern-asia | 2 |
35 | papua | 93 |
36 | ca-mrsa-endemic | 1 |
37 | je-endemic | 1 |
38 | tbrf-endemic | 1 |
39 | poliomyelitis-endemic | 1 |
40 | lower-economic | 1 |
41 | fathead | 15 |
42 | non-oecd | 1 |
43 | unpriced | 1 |
44 | advanced/ultra-advanced | 1 |
45 | ffa-induced | 3 |
46 | aspartame-induced | 1 |
47 | chemo/radiotherapy-induced | 2 |
48 | full-fledged | 2 |
49 | semantics-enabled | 1 |
50 | health-defined | 1 |
51 | less-refined | 1 |
52 | de-conditioned | 4 |
53 | less-developed | 13 |
54 | developing/developed | 1 |
55 | locally-prepared | 2 |
56 | context-based | 3 |
57 | immunologically-based | 2 |
58 | industrialised | 104 |
59 | nonindustrialised | 1 |
60 | often-unrecognised | 1 |
61 | westernised | 7 |
62 | cage-housed | 1 |
63 | reheated | 7 |
64 | shs-treated | 2 |
65 | severe/treated | 1 |
66 | hsp27-mediated | 3 |
67 | cin-related | 1 |
68 | tbi-hsct-related | 2 |
69 | non-3-hydroxylated | 2 |
70 | wnv-infected | 2 |
71 | resources-limited | 1 |
72 | dark-eyed | 2 |
73 | industrialized | 308 |
74 | western/industrialized | 1 |
75 | nonindustrialized | 2 |
76 | third-world | 2 |
77 | treatment-demand | 1 |
78 | skateboard | 1 |
79 | children-third | 4 |
80 | developing/low-resource | 1 |
81 | shunde | 3 |
82 | kofe | 1 |
83 | low-to-middle-income | 1 |
84 | low-/middle-income | 4 |
85 | high-income/middle-income | 1 |
86 | lower-income/middle-income | 1 |
87 | high-income | 194 |
88 | medium-to-low-income | 1 |
89 | oscine | 2 |
90 | chiloe | 2 |
91 | infantile-type | 4 |
92 | sylvinite | 5 |
93 | assateague | 1 |
94 | highly-conservative | 1 |
95 | tbii-positive | 1 |
96 | uk-residing | 1 |
97 | greek-speaking | 1 |
98 | developing | 10,220 |
99 | economically-developing | 1 |
100 | acquiring | 400 |
101 | amalgamating | 3 |
102 | contracting | 254 |
103 | aborting | 15 |
104 | press-fitting | 1 |
105 | yongxing | 2 |
106 | industrializing | 4 |
107 | 6th-8th | 1 |
108 | lami | 8 |
109 | 129ml | 1 |
110 | north-african | 2 |
111 | eastern-european | 1 |
112 | batan | 4 |
113 | anglo-saxan | 1 |
114 | thepollen | 1 |
115 | vaccine-driven | 1 |
116 | snrpn | 1 |
117 | seronegative/unknown | 1 |
118 | jato | 2 |
119 | medicine-demands | 1 |
120 | colares | 1 |
121 | abates | 4 |
122 | cornwallis | 2 |
123 | newly-abstinent | 2 |
124 | non-socialist | 1 |
125 | post-vertebroplasty | 2 |